Genetic heterogeneity of blood pressure (BP) effects between sexes.
LY-3885125 by Eli Lilly and Co for Non Alcoholic Fatty Liver Disease (NAFLD): Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes